Fortitude Family Office »

Sutro Biopharma shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Sutro Biopharma shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $647 56 11.57

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Mid-cap Etf Etf (VO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Sutro Biopharma

Suvretta Capital Management
Kynam Capital Management
Millennium Management
Velan Capital Investment Management
Tang Capital Management
Merck & Co
Vestal Point Capital
Eversept Partners
Samsara BioCapital
Adage Capital Partners GP
BlackRock
Renaissance Technologies
Affinity Asset Advisors
DAFNA Capital Management
Two Sigma Investments

View all funds holding Sutro Biopharma